Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
senna + lactulose
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Senna + lactulose is a combination of two laxatives that work through different mechanisms to treat constipation. Lactulose is an osmotic laxative that draws water into the intestines from surrounding body tissues, thereby softening stools and increasing their volume to stimulate bowel movement. Senna is a stimulant laxative that works by irritating the lining of the intestines, which helps stimulate muscle contractions to facilitate stool passage. This combination may be more effective than either agent alone for treating chronic constipation, particularly in elderly patients.
- Brand names
- Senokot-S
02
Targets
AQP3 (Aquaporin-3 channel protein)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on senna + lactulose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on senna + lactulose.